SynthesisBMJ open2019

Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent

Abdullah A Alhifany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.